Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
E Pérez-Herrero, A Fernández-Medarde - European journal of …, 2015 - Elsevier
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …
Therapeutic efficacy of nanoparticles and routes of administration
D Chenthamara, S Subramaniam… - Biomaterials …, 2019 - spj.science.org
In modern-day medicine, nanotechnology and nanoparticles are some of the indispensable
tools in disease monitoring and therapy. The term “nanomaterials” describes materials with …
tools in disease monitoring and therapy. The term “nanomaterials” describes materials with …
Nanoparticles in photodynamic therapy
Cancer accounted for 7.6 million deaths (around 13% of all deaths) worldwide in 2008.(1)
Almost 13 million cancer cases are newly diagnosed every year, and deaths are projected to …
Almost 13 million cancer cases are newly diagnosed every year, and deaths are projected to …
Conjugated polymer nanoparticles for imaging, cell activity regulation, and therapy
Y Wang, L Feng, S Wang - Advanced Functional Materials, 2019 - Wiley Online Library
Conjugated polymer nanoparticles, considered as a class of promising nanomaterials for
biomedical application, are extensively employed in bioimaging, anti‐microorganism and …
biomedical application, are extensively employed in bioimaging, anti‐microorganism and …
[HTML][HTML] Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review
Chitosan is a promising biopolymer for drug delivery systems. Because of its beneficial
properties, chitosan is widely used in biomedical and pharmaceutical fields. In this review …
properties, chitosan is widely used in biomedical and pharmaceutical fields. In this review …
Chitosan-based drug delivery systems
A Bernkop-Schnürch, S Dünnhaupt - European journal of pharmaceutics …, 2012 - Elsevier
Within the past 20years, a considerable amount of work has been published on chitosan
and its potential use in drug delivery systems. In contrast to all other polysaccharides having …
and its potential use in drug delivery systems. In contrast to all other polysaccharides having …
Graphene-based polymer composites and their applications
TK Das, S Prusty - Polymer-Plastics Technology and Engineering, 2013 - Taylor & Francis
Recently, graphene has attracted both academic and industrial interest because it can
produce a dramatic improvement in properties at low filler content. The utilization of …
produce a dramatic improvement in properties at low filler content. The utilization of …
Chitosan‐functionalized graphene oxide as a nanocarrier for drug and gene delivery
The covalent functionalization of graphene oxide (GO) with chitosan (CS) is successfully
accomplished via a facile amidation process. The CS‐grafted GO (GO–CS) sheets consist of …
accomplished via a facile amidation process. The CS‐grafted GO (GO–CS) sheets consist of …
Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research
S Naskar, K Kuotsu, S Sharma - Journal of drug targeting, 2019 - Taylor & Francis
Chitosan (CS) is one of the most functional natural biopolymer widely used in the
pharmaceutical field due to its biocompatibility and biodegradability. These privileges lead …
pharmaceutical field due to its biocompatibility and biodegradability. These privileges lead …
Recent advances of chitosan nanoparticles as drug carriers
JJ Wang, ZW Zeng, RZ Xiao, T Xie… - International journal …, 2011 - Taylor & Francis
Chitosan nanoparticles are good drug carriers because of their good biocompatibility and
biodegradability, and can be readily modified. As a new drug delivery system, they have …
biodegradability, and can be readily modified. As a new drug delivery system, they have …